Star Research Presentations: Potpourri

23: CLINICAL PHASE II RESULTS OF PMZ-2010 (CENTHAQUIN) AS A RESUSCITATIVE AGENT FOR HYPOVOLEMIC SHOCK

Gulati, Anil¹; Jain, Dinesh²; Agrawal, Nilesh³; Rahate, Prashant⁴; Das, Soumen⁵; Chowdhuri, Rajat⁵; Dhibar, Deba⁶; Prabhu, Madhav⁷; Haveri, Sameer⁷; Agarwal, Rohit⁸; Lavhale, Manish⁹

Author Information

¹N/A, Downers Grove, IL

²Dayanand Medical College, Ludhiana, India

³New Era Hospital, Nagpur, India

⁴Seven Star Hospital, Nagpur, India

⁵Institute of Post Graduate Medical Education and Research, Kolkata, India

⁶Post Graduate Institute of Medical Education and Research, Chandigarh, India

⁷KLE’s Dr. Prabhakar Kore Hospital and Medical Research Centre, Belgaum, India

⁸Oriana Hospital, Varanasi, India

⁹Pharmazz India Private Limited, Greater Noida, India

Critical Care Medicine 47(1):p 12, January 2019. | DOI: 10.1097/01.ccm.0000550815.69306.46

Surviving Sepsis Campaign Guidelines

Now available: Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.

Click here for additional Surviving Sepsis Campaign Resources.

Surviving Sepsis Campaign

Secondary Logo

Journal Logo

23: CLINICAL PHASE II RESULTS OF PMZ-2010 (CENTHAQUIN) AS A RESUSCITATIVE AGENT FOR HYPOVOLEMIC SHOCK

Full Text Access for Subscribers:

Institutional Users

Not a Subscriber?

Surviving Sepsis Campaign Resources

Now available: Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.

Translated Sepsis Guideline

Visualization of Article Data

Article Level Metrics

Related Links

Related Videos

Readers Of this Article Also Read

23: CLINICAL PHASE II RESULTS OF PMZ-2010 (CENTHAQUIN) AS A RESUSCITATIVE AGENT FOR HYPOVOLEMIC SHOCK : Critical Care Medicine

Full Text Access for Subscribers:

Individual Subscribers

Institutional Users

Not a Subscriber?